Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating brentuximab vedotin in combination chemotherapy for pediatric and young adult Hodgkin lymphoma across advanced-stage disease; status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Hodgkin Lymphoma
• Classic Hodgkin Lymphoma
• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Brentuximab vedotin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-05-31